Astec LifeSciences Limited — Others, 12-04-2025: Statement of utilization of issue proceeds

The company has detailed the utilization of proceeds from its recent issue, outlining that approximately ₹100 Cr will be allocated towards expanding operational capabilities and enhancing infrastructure. This strategic move is expected to strengthen the company's position in the market and support future growth initiatives. Investors may view this update positively, as it highlights a commitment to reinvesting in the business and could signal increased operational efficiency. However, close monitoring of the execution and impact of these plans will be essential to gauge their effectiveness over time.